GLP1R and atherosclerosis: Expanding the therapeutic actions of GLP-1 medicines from liver inflammation to prevention or even reversal of fibrosis in the absence of atherosclerosis would provide valuable mechanistic insights into how GLP-1 medicines improve MASH.